tirzepatide patent expiration date us Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Off-patent semaglutide in 2026: the

Patients carrying specific variants in the FTO gene, for example, may experience stronger hunger signals even on tirzepatide and benefit from higher protein targets or more frequent meals

Consistency relative to your circadian rhythm matters more than consistency relative to wall-clock time

The downside is that higher doses require drawing more liquid

Everyone metabolizes these drugs differently, and the receptor activation profiles create distinct physiological responses

The GLP-1 also achieved a similar safety profile as its previous trials, most commonly reporting GI-related events

InjectCo offers both tirzepatide and a semaglutide program, so the better choice depends on your health history, goals, provider recommendation, and budget